Kurs & Likviditet
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Medicinteknik |
16.11.2021 13:46:05 CET | Demant A/S | Financial Calendar
Company announcement no 2021-15 | 16 November 2021 |
Financial calendar 2022
27 January | Deadline for submission of items for the agenda of the annual |
18 January to 7 February
| Quiet period prior to publication of Annual Report 2021 |
8 February
| Annual Report 2021 |
10 March
| Annual general meeting |
12 April to 2 May
| Quiet period prior to publication of Interim Management Statement |
3 May
| Interim Management Statement |
26 July to 15 August
| Quiet period prior to publication of Interim Report 2022 |
16 August
| Interim Report 2022 |
19 October to 8 November
| Quiet period prior to publication of Interim Management Statement |
9 November
| Interim Management Statement |
* Please note that if a shareholder would like to have a specific item included in the agenda for the general meeting on 10 March 2022, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 27 January 2022.
Further information: Mathias Holten Møller, Head of Investor Relations Phone +45 3917 7300 |
Contacts
- Mathias Holten Møller, Director, Head of Investor Relations, +45 3913 8827, msmo@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.